AzTrials
AzTrials

Malocclusion, Angle Class INCT03129919

Arch Dimension and Inclination of the Upper and Lower Incisors Changes

A study testing Carriere SLX® (Passive self-ligating braces) and Empower® (Interactive self-ligating braces) in people with Malocclusion, Angle Class I, run by Fundación Universitaria CIEO.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

It is intended to evaluate changes in arch dimensions and incisor inclination as well as changes in the WALA Ridge in no extraction patients treated with interactive self-ligating brackets (Empower®) and passive (Carriere SLX®) at the end of the phase of alignment and leveling. Read more about this study

Who is it for?
Ages 16 to 35 years
Conditions the study is for
Malocclusion, Angle Class I
What is being tested?
Carriere SLX® (Passive self-ligating braces) and Empower® (Interactive self-ligating braces)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
15 May 2017to 1 Apr 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 35 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Complete permanent dentition, except third molars.
  • Class I malocclusion, determined by Angle ANB 2 plus or minus 2
  • Visible alveolar teeth and ridges in plaster models, the latter being compatible and checked against the morphology of the WALA Ridge clinically presented by the patient.
  • Little index with minimum Irregularity 4-6 mm.
  • Patients with x-rays of initial profile and at the end of alignment and leveling in good condition.

Who cannot join

  • Models in poor condition that do not allow measurements.
  • Patients who do not wish to participate in the study
  • Patients with cleft lip and palate
  • Patients with craniofacial anomalies
  • Patients with previous orthodontic treatment

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Arch Dimension and Inclination of the Upper and Lower Incisors Changes in Patients Treated With Interactive and Passive Self-ligation Brackets

It is intended to evaluate changes in arch dimensions and incisor inclination as well as changes in the WALA Ridge in no extraction patients treated with interactive self-ligating brackets (Empower®) and passive (Carriere SLX®) at the end of the phase of alignment and leveling. For this, study models and profile radiographs taken before the start of treatment and at the end of the alignment and leveling phase will be evaluated. The parameters to be measured are: intercanine distance, arch depth, upper and lower incisor inclination, and WALA ridge analysis

Being tested
Carriere SLX® (Passive self-ligating braces), Empower® (Interactive self-ligating braces)
Medical subject headings
Malocclusion, Angle Class I

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Carriere SLX® (Passive self-ligating braces)Device

    Changes in the inclination of the incisors, expansion of the arches at the end of the alignment and leveling phase of the orthodontic treatment

  • Empower® (Interactive self-ligating braces)Device

    Changes in the inclination of the incisors, expansion of the arches at the end of the alignment and leveling phase of the orthodontic treatment

Study groups in NCT03129919
Study groupRoleWhat they receive
Orthodontic patients treated with brackets Carriere SLX®ExperimentalSubjects requiring orthodontic treatment and will be treated with passive self-ligating braces Carriere SLX®
Receives: Device: Carriere SLX® (Passive self-ligating braces)
Orthodontic patients treated with brackets Empower®Active comparatorSubjects requiring orthodontic treatment and will be treated with interactive self-ligating braces Empower®
Receives: Device: Empower® (Interactive self-ligating braces)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incisomaxillary angle

    Angle formed by the palatal plane and the upper incisor

    Measured: At the end of the alignment and leveling phase, an average of 8 months

Secondary outcomes (2)
  1. Transverse development of the upper and lower jaws

    Cuspal and basal intercanine distance

    Measured: Each time wire is changed in the sequence suggested by the author, an average of 3 months

  2. Inclination of the lower incisor

    Incisal mandibular plane angle

    Measured: At the end of the alignment and leveling phase, an average of 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2017
  2. Study start15 May 2017 (estimated)
  3. Primary completion1 Apr 2018 (estimated)
  4. Study completion1 Apr 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03129919
Sponsor's protocol ID
0001
Status last verified
Apr 2017
First submitted
22 Mar 2017
Last updated
26 Apr 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Carriere SLX® (Passive self-ligating braces) and Empower® (Interactive self-ligating braces) in people with Malocclusion, Angle Class I, run by Fundación Universitaria CIEO.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact CLAUDIA FORERO (57-1-7437919, claudiavivian@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incisomaxillary angle (time frame: At the end of the alignment and leveling phase, an average of 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in